1. Home
  2. ARMN vs WVE Comparison

ARMN vs WVE Comparison

Compare ARMN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMN
  • WVE
  • Stock Information
  • Founded
  • ARMN 1992
  • WVE 2012
  • Country
  • ARMN Canada
  • WVE Singapore
  • Employees
  • ARMN N/A
  • WVE N/A
  • Industry
  • ARMN
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARMN
  • WVE Health Care
  • Exchange
  • ARMN Nasdaq
  • WVE Nasdaq
  • Market Cap
  • ARMN 769.7M
  • WVE 915.6M
  • IPO Year
  • ARMN N/A
  • WVE 2015
  • Fundamental
  • Price
  • ARMN $7.04
  • WVE $7.82
  • Analyst Decision
  • ARMN
  • WVE Strong Buy
  • Analyst Count
  • ARMN 0
  • WVE 13
  • Target Price
  • ARMN N/A
  • WVE $20.15
  • AVG Volume (30 Days)
  • ARMN 1.5M
  • WVE 1.2M
  • Earning Date
  • ARMN 08-12-2025
  • WVE 08-07-2025
  • Dividend Yield
  • ARMN N/A
  • WVE N/A
  • EPS Growth
  • ARMN 28.55
  • WVE N/A
  • EPS
  • ARMN 0.15
  • WVE N/A
  • Revenue
  • ARMN $560,512,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • ARMN $49.45
  • WVE N/A
  • Revenue Next Year
  • ARMN N/A
  • WVE $1.94
  • P/E Ratio
  • ARMN $44.88
  • WVE N/A
  • Revenue Growth
  • ARMN 22.28
  • WVE N/A
  • 52 Week Low
  • ARMN $3.29
  • WVE $5.04
  • 52 Week High
  • ARMN $7.23
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • ARMN 59.49
  • WVE 67.70
  • Support Level
  • ARMN $6.78
  • WVE $6.25
  • Resistance Level
  • ARMN $7.23
  • WVE $8.13
  • Average True Range (ATR)
  • ARMN 0.25
  • WVE 0.41
  • MACD
  • ARMN -0.01
  • WVE 0.13
  • Stochastic Oscillator
  • ARMN 78.80
  • WVE 92.82

About ARMN Aris Mining Corporation

Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: